Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response

Allergic contact dermatitis (ACD) is a type IV hypersensitivity mainly mediated by Th1/Th17 immune response. Topical corticosteroid is currently the first-line treatment for allergic contact dermatitis (ACD) and systemic administration of immunosuppressive drugs are used in patients with severe diss...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongchang, Thamrong, Pluangnooch, Panwadee, Hongeng, Suradej, Wongkajornsilp, Adisak, Thumkeo, Dean, Soontrapa, Kitipong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148813/
https://www.ncbi.nlm.nih.gov/pubmed/37120440
http://dx.doi.org/10.1038/s41598-023-34211-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148813/
https://www.ncbi.nlm.nih.gov/pubmed/37120440
http://dx.doi.org/10.1038/s41598-023-34211-x

Ejemplares similares